NCT06792526Not yet recruiting
Prospective Study on Monitoring Parotid Gland Injury After Radiotherapy for Head and Neck Tumors Using Multimodal Radiomics
Monitoring Salivary Gland Damage After Radiotherapy in Patients with Head and Neck Cancer Using Multimodal Radiomics
Source: ClinicalTrials.gov · Last updated 24 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Exploring a non-invasive and objective method for ultra early quantitative assessment of radiation-induced parotid gland injury. To provide a new and early method for evaluating changes in parotid gland function in clinical practice, and to guide the timing of interventions to protect the parotid gland.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 12 Jan 2025
- Start date
- 20 Jan 2025
- Primary completion date
- 20 Jul 2025
- Lead sponsor
- Hainan People's Hospital
- Diseases
- Head and neck cancer
- NCT number
- NCT06792526
What you commit to
- Study type: Observational
- Planned participants: 20
- From 20 Jan 2025 to the primary completion date, 20 Jul 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindications to MRI, such as metallic implants or claustrophobia.
- Concurrent participation in another interventional clinical trial.
Other illness
- Severe comorbid conditions, including significant renal or hepatic dysfunction.
- Any condition that may impair compliance with study procedures.
Other
- Pregnant or breastfeeding.
Who the study is looking for
- Histologically or cytologically confirmed diagnosis of nasopharyngeal carcinoma.
- Scheduled to undergo radiotherapy as part of standard treatment.
- Aged 18 years or older.
- No contraindications to MRI scans (e.g., no implanted metallic devices).
- Written informed consent has been provided.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.